The Pharmacy Times® Retail Clinical Role section is a comprehensive resource for clinical news and expert insights on issues pertaining to retail, community, and independent pharmacists.
May 16th 2025
Aficamten, a cardiac myosin inhibitor, gains FDA approval, offering hope for improved cardiovascular health in patients with obstructive hypertrophic cardiomyopathy.
First Darunavir-Based Single-Tablet Treatment Regimen for HIV Gets Approval
July 18th 2018The approval is based on data from 2, phase 3 studies, AMBER and EMERALD, which evaluated the safety and efficacy of Symtuza compared with a control regimen in adults with no prior antiretroviral (ARV) history and in virologically suppressed adults.
Read More
Nivolumab, Ipilimumab Combo Approved by FDA for MSI-H/dMMR Colorectal Cancer
July 11th 2018The FDA has granted an accelerated approval to the combination of nivolumab (Opdivo) and ipilimumab (Yervoy) for the treatment of eligible patients aged 12 years and older with microsatellite instability-high or mismatch repair deficient metastatic colorectal cancer (mCRC).
Read More